Filter
523
Filtered Results: 523
Text search:
European
Medicines
Agency
EMA
Featured
Recommendations
58
New Publications
118
Language
Document type
No document type
259
Studies & Reports
102
Guidelines
83
Manuals
31
Fact sheets
23
Strategic & Response Plan
11
Situation Updates
5
Training Material
4
Resource Platforms
2
Brochures
1
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
28
Ukraine
12
Kenya
11
Eastern Europe
11
Germany
10
Nigeria
9
Sierra Leone
8
Liberia
8
Ethiopia
8
Myanmar / Burma
8
Ghana
7
Zambia
7
Africa
7
Global
7
Tanzania
6
South Africa
6
Uganda
5
Syria
5
Guinea
4
India
4
Nepal
4
Indonesia
4
Brazil
4
Eastern Europe and Central Asia
4
Congo, Democratic Republic of
3
Zimbabwe
3
Philippines
3
Bangladesh
3
Malawi
3
Namibia
3
Yemen
3
East and Southern Africa
3
West and Central Africa
3
Venezuela
3
Albania
3
Tajikistan
3
South Sudan
2
Jordan
2
Cambodia
2
Rwanda
2
Eswatini/ Swaziland
2
Serbia
2
Colombia
2
Lesotho
2
Latin America and the Carribbean
2
Russia
2
Estonia
2
Moldova
2
Georgia
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Pakistan
1
Iraq
1
Lebanon
1
Egypt
1
Thailand
1
China
1
Papua New Guinea
1
Sudan
1
Argentina
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
El Salvador
1
Bolivia
1
Greece
1
Madagascar
1
Chile
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Armenia
1
Mongolia
1
Laos
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
66
Women & Child Health
32
Public Health
28
Key Resources
22
Pharmacy & Technologies
12
Capacity Building
5
Toolboxes
COVID-19
58
AMR
45
HIV
42
Mental Health
41
TB
38
Rapid Response
31
Pharmacy
22
Ebola
21
Planetary Health
20
Disability
16
Conflict
13
Refugee
13
Global Health Education
11
Caregiver
10
NTDs
9
Zika
7
Specific Hazards
6
Cholera
2
Polio
2
Natural Hazards
2
NCDs
2
Social Ethics
1
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim re...
The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to ...
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have s...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibio...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
Migrants in an irregular situation: access to healthcare in 10 European Union Member States
recommended
This report explores the access to healthcare granted to irregular migrants in 10 EU Member States. It focuses on migrants who are present in an irregular situation, namely those who do not fulfil conditions for entry, stay or residence. Through interviews with a range of different sources including...
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2...
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African ... Regulatory Harmonization (AMRH) Initiative, and the World Health Organisation’s (WHO) African Vaccine Regulatory Forum (AVAREF) to enable and provide support for an effective regulatory framework for COVID-19 Vaccines in Africa.
Accessed: 26.11.2019
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdd...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 ... Drug Report package.
Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en
Ukrainian Title:
УКРАЇНА: Еквівалентність лікарських засобів, зареєстрованих в Україні та інших країнах. Інформація для працівників охорони здоров'я та пацієнтів
To support t...
